The U.S. Food and Drug Administration updated its approval Tuesday of the Pfizer-BioNTech booster vaccine, making it available to some children under age 5. Before this update, children under 5 were not eligible for COVID-19 booster shots. Instead, they received three doses of the regular vaccine.
The post FDA Updates Approval of Pfizer Booster Vaccine for Children Under 5 first appeared on Post News Group.
